ArticleBMC hematology2018

More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromes.

Rory M Shallis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.